Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK/PD of BIBR 1048 MS (Dabigatran Etexilate) in Healthy Volunteers
NCT02170831Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 1999
- Primary completion
- Jul 1999
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of dabigatran in thromboembolism (5 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Activated Partial Thromboplastin Time and Prothrombin Time. Started May 1999; status: completed.
02
Drugs
dabigatran
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02170831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02170831.